Associated Banc Corp Buys 3,770 Shares of Stryker Co. (SYK)
Associated Banc Corp lifted its stake in Stryker Co. (NYSE:SYK) by 14.4% in the 1st quarter, Holdings Channel reports. The firm owned 30,036 shares of the medical technology company’s stock after purchasing an additional 3,770 shares during the period. Associated Banc Corp’s holdings in Stryker were worth $5,933,000 at the end of the most recent reporting period.
Several other large investors also recently bought and sold shares of SYK. ERTS Wealth Advisors LLC acquired a new stake in Stryker during the fourth quarter worth $25,000. Farmers National Bank acquired a new stake in Stryker during the first quarter worth $25,000. Northwest Wealth Management LLC increased its stake in Stryker by 103.6% during the fourth quarter. Northwest Wealth Management LLC now owns 169 shares of the medical technology company’s stock worth $26,000 after acquiring an additional 86 shares during the last quarter. Semmax Financial Advisors Inc. acquired a new stake in Stryker during the fourth quarter worth $28,000. Finally, Horan Securities Inc. purchased a new position in shares of Stryker during the fourth quarter worth $30,000. 74.71% of the stock is owned by hedge funds and other institutional investors.
Several research analysts have recently commented on the company. Wells Fargo & Co raised their price target on Stryker from $214.00 to $219.00 and gave the stock an “outperform” rating in a research report on Monday, April 1st. Zacks Investment Research lowered Stryker from a “buy” rating to a “hold” rating in a research report on Friday, April 12th. BTIG Research raised their price target on Stryker to $211.00 and gave the stock a “buy” rating in a research report on Monday, March 18th. Barclays raised their price target on Stryker from $203.00 to $211.00 and gave the stock an “overweight” rating in a research report on Monday, April 15th. Finally, JPMorgan Chase & Co. raised their price target on Stryker from $200.00 to $215.00 and gave the stock an “overweight” rating in a research report on Tuesday, March 19th. Six research analysts have rated the stock with a hold rating and seventeen have given a buy rating to the company’s stock. The company presently has an average rating of “Buy” and a consensus target price of $196.85.
NYSE:SYK opened at $184.14 on Monday. The firm has a market capitalization of $68.70 billion, a P/E ratio of 25.19, a P/E/G ratio of 2.24 and a beta of 0.84. Stryker Co. has a 12-month low of $144.75 and a 12-month high of $199.85. The company has a quick ratio of 1.30, a current ratio of 2.12 and a debt-to-equity ratio of 0.68.
Stryker (NYSE:SYK) last released its earnings results on Tuesday, April 23rd. The medical technology company reported $1.88 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $1.84 by $0.04. The firm had revenue of $3.52 billion during the quarter, compared to analyst estimates of $3.51 billion. Stryker had a return on equity of 26.72% and a net margin of 25.38%. Stryker’s revenue was up 8.5% compared to the same quarter last year. During the same period last year, the business posted $1.68 earnings per share. Equities research analysts predict that Stryker Co. will post 8.15 earnings per share for the current year.
The business also recently announced a quarterly dividend, which will be paid on Wednesday, July 31st. Investors of record on Friday, June 28th will be issued a $0.52 dividend. The ex-dividend date is Thursday, June 27th. This represents a $2.08 dividend on an annualized basis and a yield of 1.13%. Stryker’s dividend payout ratio (DPR) is presently 28.45%.
TRADEMARK VIOLATION WARNING: This piece was first published by The Cerbat Gem and is the property of of The Cerbat Gem. If you are viewing this piece on another website, it was stolen and reposted in violation of US and international trademark and copyright legislation. The legal version of this piece can be accessed at https://www.thecerbatgem.com/2019/05/20/associated-banc-corp-buys-3770-shares-of-stryker-co-syk.html.
Stryker Company Profile
Stryker Corporation operates as a medical technology company. The company operates through three segments: Orthopaedics, MedSurg, and Neurotechnology and Spine. The Orthopaedics segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. The MedSurg segment offers surgical equipment and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, and other medical devices for use in various medical specialties.
Read More: What is a Stop Order?
Want to see what other hedge funds are holding SYK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Stryker Co. (NYSE:SYK).
Receive News & Ratings for Stryker Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stryker and related companies with MarketBeat.com's FREE daily email newsletter.